查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587502

重組蛋白市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、宿主細胞、地區、細分市場預測，2025-2030 年

Recombinant Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies), By Application (Therapeutics), By End Use, By Host Cell (Mammalian), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

重組蛋白市場成長與趨勢

預計2030年，全球重組蛋白市場規模將達到55.8億美元，2025年至2030年複合年成長率預計為10.2%。

多發性硬化症、嗜中性白血球低下症、腦出血、貧血和侏儒症等疾病變得越來越常見，推動了對重組蛋白藥物的需求。此外，由於生技藥品開發和研究活性化，預計該行業將擴大，這將極大地支持世界產業的成長。由於癌症發病率和盛行率上升以及研發活動不斷擴大，生物相似藥、生技藥品和重組蛋白的開發越來越受到關注。

根據美國癌症協會預測，2022 年將新增 190 萬癌症病例，並有 609,360 例癌症相關死亡。此外，重組蛋白在 ELISA、蛋白質印跡和免疫組織化學 (IHC) 等臨床診斷方法中的應用越來越多，預計將推動市場擴張。由於研發支出增加、癌症患者數量增加以及對新穎和客製化治療的需求等因素，預計全球產業將在預測期內大幅擴張。 COVID-19 大流行導致重組蛋白片段的研究活動增加，以了解病毒動態。隨著客製化的治療，重組蛋白的產量顯著增加。

此外，隨著重組蛋白（尤其是與 COVID-19 相關的免疫反應蛋白）的需求和產量增加，研究資金預計將變得更加容易獲得。因此，我們看到專門針對 COVID-19 提供產品的公司產生了積極影響。重組蛋白被認為是天然蛋白的改良版本，可以透過多種方式生產，以提高蛋白質產量、製造有用的商業產品和修改基因序列。全球產業的主要驅動力是製藥公司研發成本的增加、慢性病的高發生率、監管要求的增加以及減少病毒感染的持續需求。

在預測期內，全球產業預計將受到重組蛋白合成技術進步的推動。例如，2022年6月，國家生物技術資訊中心產生的資料顯示，CRISPR/Cas9、TALEN、鋅指介導以及基因改造或順基因技術等新育種技術將比新興技術更有可能獲得核准。促進體外基因編輯或操作。此外，新興國家人口老化、收入水準提高、醫療基礎設施改善、醫療成本上升以及低成本製造等優勢預計將推動市場參與企業投資該地區並推動市場成長。

重組蛋白市場報告亮點

  • 2024年，細胞激素和生長因子細分市場佔最大佔有率，達到24.6%。預計該細分市場將在預測期內呈指數級成長。
  • 由於代謝紊亂、癌症、遺傳疾病和免疫疾病等多種疾病的流行，治療領域在 2024 年以 34.2% 的佔有率主導全球市場。
  • 2024 年，製藥和生技公司細分市場佔據最大市場佔有率，達到 38.1%。對生技藥品和生物相似藥的關注導致生物製造商在研發方面投入了數百萬美元，以擴大產品平臺、發明新技術和改進生物製程工具。
  • 2024年重組蛋白市場中，哺乳動物細分市場佔最大銷售佔有率，達42.1%。
  • 由於該地區慢性病發病率不斷上升、尖端治療方法的使用、主要企業的存在以及醫療保健支出的增加，北美將在 2024 年成為主導地區。

目錄

第1章重組蛋白市場：調查方法與範圍

第2章重組蛋白市場：執行摘要

  • 市場展望
  • 段簡介
  • 競爭格局概覽

第3章重組蛋白市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場趨勢及展望
    • 市場動態
    • 市場限制因素分析
  • 營商環境分析
    • PESTEL分析
    • 波特五力分析
    • COVID-19 影響分析

第4章 產品經營分析

  • 產品細分儀表板
  • 重組蛋白市場：產品變異分析
  • 2018-2030年全球重組蛋白市場規模及趨勢分析（分產品）
  • 細胞激素和生長因子
    • 細胞激素和生長因子市場，2018-2030
    • 干擾素(IFN)
    • 白細胞介素(IL)
    • 其他
  • 抗體
    • 抗體，2018-2030
  • 免疫查核點蛋白
    • 免疫查核點蛋白市場，2018-2030
  • 病毒抗原
    • 2018-2030年病毒抗原市場
  • 酵素
    • 酵素市場，2018-2030
    • 激酶
    • 代謝酵素
    • 其他
  • 重組調節蛋白
    • 重組調節蛋白市場，2018-2030
  • 荷爾蒙
    • 荷爾蒙市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第5章 宿主細胞業務分析

  • 宿主細胞細分儀表板
  • 重組蛋白市場：宿主細胞變異分析
  • 2018-2030年全球重組蛋白市場規模及趨勢分析（依宿主細胞）
  • 哺乳動物細胞
    • 哺乳動物細胞市場，2018-2030
  • 細菌細胞
    • 細菌細胞市場，2018-2030
  • 酵母和真菌
    • 酵母和真菌市場，2018-2030
  • 昆蟲細胞
    • 昆蟲細胞市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第6章 應用業務分析

  • 使用細分儀表板
  • 重組蛋白市場：應用變異分析
  • 2018-2030年全球重組蛋白市場規模及趨勢分析（依應用）
  • 藥物發現與開發
    • 藥物發現與開發市場，2018-2030
  • 治療
    • 生技藥品
    • 疫苗
    • 細胞/基因治療
    • 其他
  • 研究
    • 研究市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第7章 最終用途業務分析

  • 最終用途細分儀表板
  • 重組蛋白市場：最終用途變異分析
  • 2018-2030 年全球重組蛋白市場規模與趨勢分析（依最終用途）
  • 製藥和生物技術公司
    • 製藥和生物技術市場，2018-2030
  • 學術研究所
    • 學術研究機構市場，2018-2030
  • 其他
    • 其他市場，2018-2030

第8章區域業務分析

  • 區域儀表板
  • 2024 年和 2030 年按地區分類的全球市場佔有率
  • 北美洲
    • 北美重組蛋白市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲重組蛋白市場，2018-2030
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太重組蛋白市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 拉丁美洲重組蛋白市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 中東和非洲重組蛋白市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司分類
  • 策略規劃
  • 2024 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Sino Biological, Inc.
    • GenScript
    • Bio-Techne
    • Proteintech Group, Inc.
    • Enzo Life Sciences, Inc.
    • Abnova Corp
    • RayBIoTech Life Inc.
    • STEMCELL Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
Product Code: GVR-4-68039-974-2

Recombinant Proteins Market Growth & Trends:

The global recombinant proteins market size is expected to reach USD 5.58 billion in 2030 and is projected to grow at a CAGR of 10.2% from 2025 to 2030. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.

According to the American Cancer Society, in 2022, there will be 1.9 million new cancer cases and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period. Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19. Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The main drivers of the global industry are the rise in pharmaceutical firms' R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling market growth.

Recombinant Proteins Market Report Highlights:

  • The cytokines & growth factors segment held the largest share of 24.6% of the market in 2024. This segment is anticipated to grow exponentially throughout the forecast period.
  • The therapeutics segment dominated the global market with a share of 34.2% in 2024 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases.
  • The pharma & biotechnology companies segment captured the largest market share of 38.1% in 2024. The inclination towards biologics and biosimilars has resulted in a cascade of multi-million investments by bio-manufacturers in R&D to grow the pipeline of products, devise new technologies, and advance bioprocessing tools.
  • The mammalian segment held the largest revenue share of 42.1% of the recombinant proteins market in 2024.
  • North America was the dominant region in 2024 due to an increase in the incidence of chronic diseases, use of cutting-edge treatments, the presence of key players, and a rise in healthcare spending in the region.

Table of Contents

Chapter 1. Recombinant Proteins Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Host Cell Segment
    • 1.2.3. Application Segment
    • 1.2.4. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Recombinant Proteins Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Recombinant Proteins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
    • 3.2.1. Market Dynamics
      • 3.2.1.1. Increasing Investments In Research & Development Activities
      • 3.2.1.2. Growing research activities for drug discovery and precision medicine
      • 3.2.1.3. Rising adoption of biologics & biosimilars
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory and safety concerns regarding protein production
      • 3.2.2.2. Dearth of skilled personnel and expertise
  • 3.3. Business Environment Analysis
    • 3.3.1. PESTEL Analysis
    • 3.3.2. Porter's Five Forces Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Recombinant Proteins Market: Product Movement Analysis
  • 4.3. Global Recombinant Proteins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cytokines & Growth Factors
    • 4.4.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
    • 4.4.2. Interferons (IFNs)
      • 4.4.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
    • 4.4.3. Interleukins (ILs)
      • 4.4.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Antibodies
    • 4.5.1. Antibodies, 2018 - 2030 (USD Million)
  • 4.6. Immune Checkpoint Proteins
    • 4.6.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
  • 4.7. Virus Antigens
    • 4.7.1. Virus Antigens Market, 2018 - 2030 (USD Million)
  • 4.8. Enzymes
    • 4.8.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.2. Kinases
      • 4.8.2.1. Kinases Market, 2018 - 2030 (USD Million)
    • 4.8.3. Metabolic Enzymes
      • 4.8.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
    • 4.8.4. Others
      • 4.8.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.9. Recombinant Regulatory Proteins
    • 4.9.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
  • 4.10. Hormones
    • 4.10.1. Hormones Market, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Host Cell Business Analysis

  • 5.1. Host Cell Segment Dashboard
  • 5.2. Recombinant Proteins Market: Host Cell Movement Analysis
  • 5.3. Global Recombinant Proteins Market Size & Trend Analysis, by Host Cell, 2018 to 2030 (USD Million)
  • 5.4. Mammalian Cells
    • 5.4.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
  • 5.5. Bacterial Cells
    • 5.5.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
  • 5.6. Yeast & Fungi
    • 5.6.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
  • 5.7. Insect Cells
    • 5.7.1. Insect Cells Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Recombinant Proteins Market: Application Movement Analysis
  • 6.3. Global Recombinant Proteins Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Drug Discovery & Development
    • 6.4.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 6.5. Therapeutics
    • 6.5.1. Biologics
      • 6.5.1.1. Biologics Market, 2018 - 2030 (USD Million)
    • 6.5.2. Vaccines
      • 6.5.2.1. Vaccines Market, 2018 - 2030 (USD Million)
    • 6.5.3. Cell & Gene Therapies
      • 6.5.3.1. Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others Market, 2018 - 2030 (USD Million)
  • 6.6. Research
    • 6.6.1. Research Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Recombinant Proteins Market: End-use Movement Analysis
  • 7.3. Global Recombinant Proteins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Global Market Share By Region, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. U.S. Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Canada Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. UK Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Germany Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.4. Spain
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Spain Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.5. France
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. France Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.6. Italy
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Italy Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Denmark Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Sweden Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Norway Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia-Pacific Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Japan Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. China Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. India Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. South Korea Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Thailand Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Australia Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Brazil Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Mexico Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Scenario
      • 8.6.4.4. Argentina Recombinant Proteins Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. South Africa Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Saudi Arabia Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. UAE Recombinant Proteins Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Kuwait Recombinant Proteins Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Sino Biological, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Benchmarking
      • 9.4.2.3. Strategic Initiatives
    • 9.4.3. GenScript
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Bio-Techne
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Proteintech Group, Inc.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Benchmarking
      • 9.4.5.3. Strategic Initiatives
    • 9.4.6. Enzo Life Sciences, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Abnova Corp
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Benchmarking
      • 9.4.7.3. Strategic Initiatives
    • 9.4.8. RayBiotech Life Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Benchmarking
      • 9.4.8.3. Strategic Initiatives
    • 9.4.9. STEMCELL Technologies Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Benchmarking
      • 9.4.9.3. Strategic Initiatives
    • 9.4.10. Bio-Rad Laboratories, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Benchmarking
      • 9.4.10.3. Strategic Initiatives
    • 9.4.11. Merck KGaA
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Benchmarking
      • 9.4.11.3. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 7 Global Recombinant Protein Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 12 North America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 13 U.S. Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 16 U.S. Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 17 Canada Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 20 Canada Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 21 Mexico Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 23 Mexico Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 24 Mexico Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 25 Europe Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Europe Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 29 Europe Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 30 Germany Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Germany Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 33 Germany Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 34 UK Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 UK Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 UK Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 37 UK Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 38 France Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 France Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 France Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 41 France Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 42 Italy Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Italy Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 45 Italy Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 46 Spain Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Spain Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 49 Spain Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 50 Denmark Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Denmark Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 53 Denmark Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 54 Sweden Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Sweden Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 57 Sweden Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 58 Norway Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Norway Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 61 Norway Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million
  • Table 62 Asia Pacific Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 67 China Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 China Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 70 China Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 71 Japan Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Japan Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 74 Japan Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 75 India Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 India Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 India Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 78 India Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 79 South Korea Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Korea Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 83 Australia Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Australia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 86 Australia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 87 Thailand Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 90 Thailand Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 91 Latin America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 94 Latin America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 95 Latin America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 96 Brazil Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Brazil Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 99 Brazil Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 100 Argentina Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Argentina Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 103 Argentina Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 109 South Africa Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 111 South Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 112 South Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 117 UAE Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 UAE Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 120 UAE Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Recombinant Protein Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
  • Table 125 Participant's Overview
  • Table 126 Financial Performance
  • Table 127 Key Companies Undergoing Expansions
  • Table 128 Key Companies Undergoing Acquisitions
  • Table 129 Key Companies Undergoing Collaborations
  • Table 130 Key Companies Launching New Products/Services
  • Table 131 Key Companies Undergoing Partnerships
  • Table 132 Key Companies Undertaking Other Strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Recombinant Protein, Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis
  • Fig. 11 Market Restraint Relevance Analysis (Porter's Five Forces Analysis
  • Fig. 12 Global Recombinant Protein Market: Product Movement Analysis
  • Fig. 13 Global Recombinant Protein Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 14 Global Recombinant Protein Market: Application Movement Analysis
  • Fig. 15 Global Recombinant Protein Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
  • Fig. 16 Global Recombinant Protein Market, for Therapeutics, 2018 - 2030 (USD Million)
  • Fig. 17 Global Recombinant Protein Market, for Research , 2018 - 2030 (USD Million)
  • Fig. 18 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Recombinant Protein Market: End Use Movement Analysis
  • Fig. 20 Global Recombinant Protein Market, for Pharma & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 21 Global Recombinant Protein Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 22 Global Recombinant Protein Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
  • Fig. 23 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 24 Global Recombinant Protein Market: Host Cell Movement Analysis
  • Fig. 25 Global Recombinant Protein Market, for Mammalian systems, 2018 - 2030 (USD Million)
  • Fig. 26 Global Recombinant Protein Market, for Insect Cells, 2018 - 2030 (USD Million)
  • Fig. 27 Global Recombinant Protein Market, for Yeast & Fungi, 2018 - 2030 (USD Million)
  • Fig. 28 Global Recombinant Protein Market, for Bacterial Cells, 2018 - 2030 (USD Million)
  • Fig. 29 Global Recombinant Protein Market, for Others , 2018 - 2030 (USD Million)
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2024 & 2030
  • Fig. 32 Global Recombinant Protein Market: Region Movement Analysis
  • Fig. 33 North America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 34 US Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 39 UK Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 40 France Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 48 China Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 49 India Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait Recombinant Protein Market, 2018 - 2030 (USD Million)
  • Fig. 61 Market participant categorization
  • Fig. 62 Recombinant Proteins Market Position Analysis, 2024
  • Fig. 63 Strategy framework